Background and aims: The impact of electronic cigarettes (ECs) on nicotine use is hotly debated: some fear that ECs are a ‘catalyst’ to conventional smoking, while others argue that they divert adolescents from the more harmful product. This study used simulation modeling to evaluate the plausibility of catalyst and diversion hypotheses against real‐world data.Design: A simulation model represented life‐time exclusive EC use, exclusive conventional smoking and dual use as separate subpopulations. The ‘catalyst’ effect was modeled as EC use increasing dual use initiation (i.e. EC users also start smoking). The ‘diversion’ effect was modeled as EC use decreasing exclusive cigarette initiation. The model was calibrated using data from the US National Youth Tobacco Survey (NYTS). The plausibility of each scenario was evaluated by comparing simulated trends with NYTS data. This is the first study, to our knowledge, to estimate the magnitude of a diversion effect through simulation.Setting: United States.Participants and measurements: Adolescents aged 12–17 years in NYTS, a cross‐sectional study from 2000 to 2019 (n = 12 500 to 31 000 per wave). Exclusive cigarette use, exclusive EC use and dual use of both products were defined using cumulative life‐time criteria (100+ cigarettes smoked and/or > 100 days vaped).Findings: A null model (no catalyst or diversion) over‐predicts NYTS smoking by up to 87%. Under the conservative assumption that the catalyst effect accounts for all dual use, an exponential decay constant of 19.6% EC users/year initiating smoking is required; however, this further over‐predicts actual smoking by up to 109%. A diversion effect with an exponential decay constant of 55.4%/year or 65.4%/year, with the maximum possible opposing catalyst effect also active, is required optimally to match NYTS smoking trends (root mean square error = 286 632 versus 391 396 in the null model).Conclusions: A simulation model shows that a substantial diversion effect is needed to explain observed nicotine use trends among US adolescents, and it must be larger than any possible opposing catalyst effect, if present.
Background: If US adults who smoke cigarettes are switching to e-cigarettes, the effect may be observable at the population level: smoking prevalence should decline as e-cigarette prevalence increases, especially in sub-populations with highest e-cigarette use. This study aimed to assess such effects in recent nationally-representative data. Methods: We updated a prior analysis with the latest available National Health Interview Survey data through 2022. Data were cross-sectional estimates of the yearly prevalence of smoking and e-cigarette use, respectively, among US adults and among specific age, race/ethnicity, and sex subpopulations. Non-linear models were fitted to observed smoking prevalence in the pre-e-cigarette era, with a range of ‘cut-off’ years explored (i.e., between when e-cigarettes were first introduced to when they became widely available). These trends were projected forward to predict what smoking prevalence would have been if pre-e-cigarette era trends had continued uninterrupted. The difference between actual and predicted smoking prevalence (‘discrepancy’) was compared to e-cigarette use prevalence in each year in the e-cigarette era to investigate whether the observed decline in smoking was statistically associated with e-cigarette use. Results: Observed smoking prevalence in the e-cigarette era was significantly lower than expected based on pre-e-cigarette era trends; these discrepancies in smoking prevalence grew as e-cigarette use prevalence increased, and were larger in subpopulations with higher e-cigarette use, especially younger adults aged 18–34. Results were robust to sensitivity tests varying the analysis design. Conclusions: Population-level data continue to suggest that smoking prevalence has declined at an accelerated rate in the last decade in ways correlated with increased uptake of e-cigarette use.
Studies have suggested that some US adult smokers are switching away from smoking to e-cigarette use. Nationally representative data may reflect such changes in smoking by assessing trends in cigarette and e-cigarette prevalence. The objective of this study is to assess whether and how much smoking prevalence differs from expectations since the introduction of e-cigarettes. Annual estimates of smoking and e-cigarette use in US adults varying in age, race/ethnicity, and sex were derived from the National Health Interview Survey. Regression models were fitted to smoking prevalence trends before e-cigarettes became widely available (1999–2009) and trends were extrapolated to 2019 (counterfactual model). Smoking prevalence discrepancies, defined as the difference between projected and actual smoking prevalence from 2010 to 2019, were calculated, to evaluate whether actual smoking prevalence differed from those expected from counterfactual projections. The correlation between smoking discrepancies and e-cigarette use prevalence was investigated. Actual overall smoking prevalence from 2010 to 2019 was significantly lower than counterfactual predictions. The discrepancy was significantly larger as e-cigarette use prevalence increased. In subgroup analyses, discrepancies in smoking prevalence were more pronounced for cohorts with greater e-cigarette use prevalence, namely adults ages 18–34, adult males, and non-Hispanic White adults. Population-level data suggest that smoking prevalence has dropped faster than expected, in ways correlated with increased e-cigarette use. This population movement has potential public health implications.
Youth use of electronic cigarettes ("e-cigarettes") is an ongoing concern. Vaping is usually assumed to be of nicotine, but survey responses may also include vaping of non-nicotine substances (particularly cannabis), which can impose different risks. The current study quantifies the proportions of nicotine-specific and cannabis-specific vaping among adolescents. Data from the Monitoring the Future (MTF) 2021 survey were analyzed with respect to the substance vaped: nicotine, cannabis, or flavoring only. Past-30-day (P30D) nicotine-specific vaping (exclusively, or also having vaped other substances) and cannabis-specific vaping were calculated. Results were also broken down by grade level, cigarette smoking history (current, former, or never), and frequency of e-cigarette use (<20 vs. 20+ days in P30D). Among 4706 P30D e-cigarette users, 84.2% vaped nicotine; the remaining 15.8% reported not vaping any nicotine in P30D. Cannabis vaping was reported by 48.4% of P30D vapers. Vaping both nicotine and cannabis in P30D was more common in current and former smokers than in never-smokers, and in frequent vapers (of any substance). Conversely, never-smokers were more commonly vaping cannabis but not nicotine, compared to current and former smokers. Supplementary NYTS 2022 analyses were consistent with these findings. A notable proportion of self-reported P30D vapers reported not vaping nicotine; nearly half vaped cannabis. Capturing the variety of substances used in vaping devices is imperative for accurate public health surveillance of both nicotine and cannabis vaping among US adolescents, considering their different respective harms and regulatory frameworks.